Stoudemire named IHQI's Newest Quality and Safety Fellow

As IHQI's newest Quality & Safety Fellow, Will Stoudemire, MD, is leading an initiative to reduce acute kidney injury (AKI) from nephrotoxic medications in pediatric patients.

UNC Institute for Healthcare Quality Improvement is pleased to announce Will Stoudemire, MD, has been selected as IHQI’s newest Quality & Safety Fellow. IHQI’s Quality & Safety Fellowship develops medical staff to lead improvement in healthcare quality and patient safety. As a Quality & Safety Fellow, Stoudemire is leading an initiative to reduce acute kidney injury (AKI) from nephrotoxic medications in pediatric patients. Working closely with UNC Medical Center Department of Pharmacy, Stoudemire and the improvement team are implementing AKI prevention pathways, including improved screening for AKI and hydration protocols among patients with high nephrotoxic medication exposure. The project is guided by Stoudemire’s Quality & Safety Fellowship Committee:

• Mike Steiner, MD (Committee Chair), General Pediatrics & Adolescent Medicine
• Celia Loughlin, MD, Pediatric Pulmonology
• Kristin Murphy, PharmD, UNC Pharmacy
• Darren DeWalt, MD, General Internal Medicine & Epidemiology
• Laura Brown, MPH, UNC Institute for Healthcare Quality Improvement

As a resident, Stoudemire helped to reduce care variation and improve time to treatment of pediatric asthma in the UNC Emergency Department as described here. Now a third-year Pediatric Pulmonary Fellow, Stoudemire teaches improvement at Physician Engagement in Quality and Safety (PEQS), a six-hour course that highlights physicians’ role as leaders in healthcare improvement. In addition, Stoudemire is mentoring Nicole Damari, MS4, as part of the School of Medicine’s Scholarly Concentration in Quality & Safety. Stoudemire has also received funding from the Cystic Fibrosis Foundation to develop an infection rate monitoring tool that Cystic Fibrosis Centers can use to reduce spread of infection between patients.